What's The BUZZ?

Market News, Products, Services, and Trends

Summary of Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs) Guidance for Industry

Read More

In August of 2023, the FDA published a guidance document for evaluating the acceptable intake (AI) limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs). This guidance allows for the calculation of specific AI limits for NDSRIs, based on the mutagenic and carcinogenic risk, which can range from 26.5 ng/day (the limit from past guidance) up to 1500 ng/day…


Read the full guidance here.


TODAY'S POSTS
SUBSCRIBE

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

PROFILE
LINKEDIN
WEBSITE

This post is related to:

TODAY'S POSTS

Connect with RXinsider

Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.

Subscribe
Advertise

RXinsider
1300 Division Road, Suite 103
West Warwick, RI 02893

The BUZZ / News

Publications

Marketplace

Multimedia Content

Market Intelligence

Career Center

Subscribe

Company

Subscribe
© 2025 RXinsider | All Rights Reserved.

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Summary of Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs) Guidance for Industry

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe